Department of Gastrointestinal Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Department of Gastrointestinal Surgery, Mitsui Memorial Hospital, 1 Kanda Izumi, Chiyoda, Tokyo, 101-8643, Japan.
Surg Endosc. 2018 May;32(5):2249-2254. doi: 10.1007/s00464-017-5918-x. Epub 2018 Mar 1.
The aim of this retrospective study was to assess postoperative quality of life (QOL) after robot-assisted radical transmediastinal esophagectomy, defined as a nontransthoracic esophagectomy with radical mediastinal lymphadenectomy combining a robotic transhiatal approach and a video-assisted cervical approach. The results were compared to those of transthoracic esophagectomy.
In this study, all consecutive patients who underwent robot-assisted radical transmediastinal esophagectomy or transthoracic esophagectomy for esophageal cancer at University of Tokyo between January 2010 and December 2014 were included. The European Organization for Research and Treatment of Cancer (EORTC)'s quality of life questionnaires QLQ-C30 and QLQ-OES18 were sent to all patients that were still living, had no recurrence or other malignancy, and had not undergone a reoperation because of complications after esophagectomy.
We were able to survey 63 (98.4%) of 64 eligible patients. We assessed and compared the QOL scores of both groups of patients. Compared to transthoracic esophagectomy, transmediastinal esophagectomy was associated with better QOL. Global health status and the physical, role, and cognitive function scale scores were significantly superior in the transmediastinal esophagectomy group (P = 0.004, < 0.0001, 0.007, 0.002, respectively). Fatigue, nausea and vomiting, pain, appetite loss, reflux, and taste scores were significant lower (superior) in the transmediastinal esophagectomy group (P = 0.003, 0.032, 0.025, 0.018, 0.001, 0.041, respectively).
This study indicates that robot-assisted radical transmediastinal esophagectomy is associated with better postoperative QOL compared to transthoracic esophagectomy. A larger study and prospective analyses are needed to confirm the current results.
本回顾性研究旨在评估机器人辅助经纵隔根治性食管切除术(定义为非经胸食管切除术,根治性纵隔淋巴结清扫术,结合机器人经食管裂孔入路和辅助颈部入路)的术后生活质量(QOL)。结果与经胸食管切除术进行了比较。
本研究纳入了 2010 年 1 月至 2014 年 12 月期间在东京大学接受机器人辅助经纵隔根治性食管切除术或经胸食管切除术治疗食管癌的所有连续患者。将欧洲癌症研究与治疗组织(EORTC)的生活质量问卷 QLQ-C30 和 QLQ-OES18 发送给所有仍存活、无复发或其他恶性肿瘤、且未因术后并发症而行再次手术的患者。
我们能够调查 63 例(64 例中的 98.4%)合格患者。我们评估并比较了两组患者的 QOL 评分。与经胸食管切除术相比,经纵隔食管切除术与更好的 QOL 相关。全球健康状况以及身体、角色和认知功能量表评分在经纵隔食管切除术组中显著更高(P=0.004、<0.0001、0.007、0.002)。经纵隔食管切除术组的疲劳、恶心和呕吐、疼痛、食欲减退、反流和味觉评分显著较低(更好)(P=0.003、0.032、0.025、0.018、0.001、0.041)。
本研究表明,与经胸食管切除术相比,机器人辅助经纵隔根治性食管切除术与更好的术后 QOL 相关。需要更大规模的研究和前瞻性分析来证实目前的结果。